Epidemiology of hepatitis B in Canadian blood donors

Transfusion

Volumn 48, Issue 11, 2008, Pages 2323-2330

  O'Brien, Sheila F ^a   Xi, Guoliang ^b   Fan, Wenli ^b   Yi, Qi Long ^b   Fearon, Margaret A ^b   Scalia, Vito ^b   Goldman, Mindy ^b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; BLOOD DONOR; CANADA; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS B; HUMAN; IMMIGRATION; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; RISK FACTOR; VACCINATION;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; ASIA; BLOOD DONORS; CANADA; CASE-CONTROL STUDIES; EMIGRANTS AND IMMIGRANTS; ENDEMIC DISEASES; EUROPE; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; VACCINATION;

EID: 55349100893     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01845.x     Document Type: Article

References (23)

1. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. Transfusion 2007 47 : 1809 15.
2. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 25.
3. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated windowperiod risk in the American Red Cross blood donor population. Transfusion 2002 42 : 966 72.
4. Pillonel J, Le Marrec N, Girault A, David D, Laperche S Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003 Transfus Clin Biol 2005 12 : 239 46 (in French).
5. Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J 2005 35 : 592 8.
6. Van der Bij AK, Coutinho RA, Van der Poel CL. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006 46 : 1663 6.
7. Polizzotto MN, Wood EM, Ingham H, Keller AJ. Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008 48 : 55 63.
8. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M, Delange G. Declining hepatitis C rates in first-time blood donors: insights from surveillance and case-control risk factor studies. Transfusion 2008 48 : 902 9.
9. Statistics Canada. 2001 Census; Canada's ethnocultural portrait: the changing mosaic. Ottawa (ON) : Statistics Canada c2008 cited 2008 Feb 4]. Available from: http://www12.statcan.ca/English/census01/products/analytic/ companion/etoimm/canada.cfm
10. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999 116 : 893 9.
11. Zhang J, Zou S, Giulivi A. Epidemiology of hepatitis B in Canada. Can J Infect Dis 2001 12 : 345 50.
12. Tepper M, Gully P. Hepatitis B. Can Med Assoc J 1997 156 : 1033 4.
13. Delage G, Montplaisir S, Remy-Prince S, Pierri E. Prevalence of hepatitis B virus infection in pregnant women in the Montreal area. CMAJ 1986 134 : 897 901.
14. Munroe V, Pielak K. A school-based hepatitis B immunization program for British Columbia. Can J School Health 1996 66 : 229 32.
15. Gilca V, Duval B, Boulianne N, Dion R, De Serres G. Impact of the Quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program. Pediatr Infect Dis J 2006 25 : 372 4.
16. Patrick DM, Bigham M, Ng H, White R, Tweed A, Skowronski DM. Elimination of acute hepatitis B among adolescents after one decade of an immunization program targeting Grade 6 students. Pediatr Infect Dis J 2003 22 : 874 7.
17. Cheung J, Lee TK, The CZ, Wang CY, Kwan WC, Yoshida EM. Cross-sectional study of hepatitis B awareness among Chinese and Southeast Asian Canadians in the Vancouver-Richmond community. Can J Gastroenterol 2005 19 : 245 9.
18. Lai DW, Chau SB. Effects of service barriers on health status of older Chinese immigrants in Canada. Soc Work 2007 52 : 261 9.
19. Su FH, Huang HY, Chang HJ, Jeng JJ, Liu YH, Chen CD. Forecasting the declining rate of chronic hepatitis-B carrier status at a Taiwanese university: twenty years after implementation of an universal HBV vaccination program in Taiwan. Chang Gung Med J 2007 30 : 521 8.
20. FitzSimons D, Francois G, Hall A, McMahon B, Meheus A, Zanetti A, Duval B, Jilg W, Bocher WO, Lu SN, Akarca U, Lavanchy D, Goldstein S, Banatvala J, Van Damme P. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005 23 : 4158 66.
21. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995 35 : 475 7.
22. Sharma S, Saini N, Arora L, Chawla Y, Dueseja A. Prolonged hepatitis B surface antigen positivity in hepatitis B vaccine recipients. Dig Liver Dis 2006 38 : 860 1.
23. Stramer SL. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not. Transfusion 2005 45 : 1242 6.